{"schema_version":"secwatch.filing_event.v1","accession":"0001731122-26-000871","form_type":"8-K","ticker":"LNAI","cik":"0001527728","company_name":"Lunai Bioworks Inc.","filed_at":"2026-06-17T20:32:20+00:00","discovered_at":"2026-06-17T20:33:00.249465+00:00","generated_at":"2026-06-17T20:35:21.785190+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Lunai Bioworks lands first defense contract, sues naked short sellers over 81.6% FTD shares","bullets":["Secured first revenue-generating multi-year defense collaboration via BioSymetrics for chemical threat assessment.","Formed Pathfinder Consortium with Harvard, Brigham & Women's, Purdue, Utah, Colorado for biodefense.","Partnered with BrainStorm Therapeutics; awarded $1.85M NIH STTR grant for alcohol use disorder.","Filed May 2026 lawsuit against unidentified parties; 29.6M fails-to-deliver (81.6% of shares); court granted expedited discovery.","Achieved compliance with Nasdaq listing requirements."],"urls":{"canonical":"https://secwatch.observer/filing/0001731122-26-000871","json":"https://secwatch.observer/filing/0001731122-26-000871.json","markdown":"https://secwatch.observer/filing/0001731122-26-000871.md","text":"https://secwatch.observer/filing/0001731122-26-000871.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1527728/000173112226000871/0001731122-26-000871-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1527728/000173112226000871/e7731_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T20:35:21.785190+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}